At Tiefenbacher Group, our focus goes beyond developing medicines. We create value-added and innovative therapies by understanding the needs and challenges of everyday healthcare. By listening to patients and healthcare professionals, we turn real-world needs into practical pharmaceutical solutions – from more convenient dosing and improved drug delivery to new treatment options, OTC products and enhanced side-effect profiles.
For Stefanie Abt, Director of Portfolio and Innovation, Project Management and Market Access, this means connecting innovation with execution. 🤝 From identifying unmet needs and shaping the right product concepts to coordinating development projects and bringing new solutions closer to patients. 🌍
Creating better therapies is not just about developing new drugs. It is about listening, understanding, and translating insights into treatments that improve the everyday lives of patients around the world. 💙
